|
MCM6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.803100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.896400E-01 |
| Normal-vs-Stage2 |
4.609800E-01 |
| Normal-vs-Stage3 |
1.924940E-03 |
| Normal-vs-Stage4 |
6.509800E-02 |
| Stage1-vs-Stage2 |
5.708800E-01 |
| Stage1-vs-Stage3 |
2.961000E-03 |
| Stage1-vs-Stage4 |
1.105600E-02 |
| Stage2-vs-Stage3 |
2.452200E-02 |
| Stage2-vs-Stage4 |
1.181000E-01 |
| Stage3-vs-Stage4 |
7.431800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.008100E-02 |
| Normal-vs-AfricanAmerican |
4.179900E-02 |
| Normal-vs-Asian |
1.697630E-01 |
| Caucasian-vs-AfricanAmerican |
5.280200E-01 |
| Caucasian-vs-Asian |
1.275440E-01 |
| AfricanAmerican-vs-Asian |
1.651370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.714800E-01 |
| Normal-vs-Female |
1.63618999999837E-05 |
| Male-vs-Female |
3.53619999999832E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.903380E-01 |
| Normal-vs-Extreme_Weight |
9.971200E-01 |
| Normal-vs-Obese |
1.274060E-02 |
| Normal-vs-Extreme_Obese |
4.635100E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.731630E-01 |
| Normal_Weight-vs-Obese |
1.838610E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.411600E-02 |
| Extreme_Weight-vs-Obese |
1.450350E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.162000E-02 |
| Obese-vs-Extreme_Obese |
3.775400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.043800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.664140E-03 |
| Normal-vs-Age(61-80Yrs) |
7.866200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.921800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.214100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.274100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.222100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.959900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.440100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.192600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.102800E-01 |
| Normal-VS-Type2 PRCC |
4.334300E-02 |
| Normal-VS-KIRP CIMP |
5.283700E-03 |
| Normal-VS-Unclassified PRCC |
4.708400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.582300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.499300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.937500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.014290E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.985600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.089950E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.732200E-01 |
| Normal-vs-N1 |
2.003500E-03 |
| Normal-vs-N2 |
1.071630E-01 |
| N0-vs-N1 |
6.355700E-03 |
| N0-vs-N2 |
2.009500E-02 |
| N1-vs-N2 |
9.491800E-01 |
|
|
